Relmada Therapeutics Inc Net Asset Quality Index
Relmada Therapeutics Inc net asset quality index. Relmada Therapeutics Inc (RLMD) has a Net Asset Quality Index of 92.9% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $235.36 Million minus total liabilities of $16.63 Million yields net assets of $218.73 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check earnings quality score of Relmada Therapeutics Inc to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Relmada Therapeutics Inc (2012–2025)
Net asset quality index of Relmada Therapeutics Inc from 2012 to 2025. This chart shows how Relmada Therapeutics Inc's Net Asset Quality Index has evolved across 15 annual periods from 2012 to 2025. As of March 2026, the index stands at 92.9%, representing net assets of $218.73 Million against total assets of $235.36 Million USD. See RLMD net asset value for net asset value and shareholders' equity analysis.
Relmada Therapeutics Inc Net Asset Quality Index by Year (2012–2025)
Relmada Therapeutics Inc net asset quality index by year from 2012 to 2025. The table below presents the year-by-year Net Asset Quality Index for Relmada Therapeutics Inc from 2012 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Relmada Therapeutics Inc (RLMD) total market value.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 92.0% | $86.51 Million | $94.00 Million | $7.49 Million | ▲ +14.5 pp |
| 2024 | 77.5% | $35.52 Million | $45.82 Million | $10.30 Million | ▼ -10.0 pp |
| 2023 | 87.5% | $85.36 Million | $97.55 Million | $12.19 Million | ▼ -4.3 pp |
| 2022 | 91.8% | $140.44 Million | $152.91 Million | $12.47 Million | ▼ -1.4 pp |
| 2021 | 93.3% | $208.26 Million | $223.33 Million | $15.06 Million | ▲ +3.9 pp |
| 2020 | 89.3% | $105.58 Million | $118.19 Million | $12.60 Million | ▼ -9.4 pp |
| 2019 | 98.8% | $115.68 Million | $117.14 Million | $1.46 Million | ▲ +279.6 pp |
| 2018 | -180.9% | $-5.51 Million | $3.05 Million | $8.56 Million | ▼ -232.3 pp |
| 2017 | 51.5% | $1.46 Million | $2.84 Million | $1.38 Million | ▼ -17.3 pp |
| 2016 | 68.7% | $7.04 Million | $10.24 Million | $3.20 Million | ▲ +32.6 pp |
| 2015 | 36.1% | $8.81 Million | $24.39 Million | $15.58 Million | ▲ +0.0 pp |
| 2014 | 36.1% | $8.81 Million | $24.39 Million | $15.58 Million | ▲ +40.4 pp |
| 2014 | -4.3% | $-1.11 Million | $25.76 Million | $26.87 Million | ▲ +0.0 pp |
| 2013 | -4.3% | $-1.11 Million | $25.76 Million | $26.87 Million | ▼ -66.2 pp |
| 2012 | 61.9% | $11.36K | $18.35K | $7.00K | — |